New to The Street Episode #678 to Air on Bloomberg TV Featuring Game-Changing Innovators in AI, Biotech, Blockchain, and Sustainability
New to The Street, the leading multi-platform financial news series, announces its upcoming Bloomberg Television broadcast, airing Saturday, July 12 at 6:30 PM EST. Episode #678 showcases five transformative companies leading advancements across artificial intelligence, healthcare, sustainability, and blockchain. This dynamic lineup brings powerful insights from visionary leaders shaping the future of their respective industries.
Featured Segments in Episode #678:
Hapbee Technologies (OTCQB:HAPBF)
NBA All-Star Jaylen Brown shares how Hapbee's groundbreaking wearable neurotech helps optimize sleep, recovery, and cognitive performance-without pharmaceuticals. The device uses proprietary low-frequency signals to emulate the effects of popular compounds, empowering users to choose how they feel, naturally and safely.
Arrive AI (NASDAQ:ARAI)
Live from Nasdaq MarketSite in Times Square, host Ana Berry interviews CEO Dan O'Toole and Chief Strategy Officer Neerav Shah as they unveil Arrive's secure smart mailbox technology. Phase 1 launches in healthcare and logistics; Phase 2 expands to every U.S. ZIP code. Arrive beat Amazon to the patent by four days, reinforcing its first-mover advantage in the $150B+ last-mile delivery sector.
FLOKI (CRYPTO:FLOKI)
Pedro Vidal, FLOKI's Community Relations Officer, discusses the explosive success of Valhalla, its play-to-earn metaverse game. As FLOKI expands across DeFi, NFTs, and blockchain gaming, its highly engaged global community cements it as one of crypto's most disruptive and culturally relevant brands. Learn more at www.floki.com.
BioVie Inc. (NASDAQ:BIVI)
CEO Cuong Do and Chief Medical Officer Joseph Palumbo join Jane King to share meaningful updates on BioVie's advancement in clinical trials targeting Alzheimer's, Parkinson's, and Long COVID. BioVie is the only company to receive a federal grant to study Long COVID, and is currently enrolling patients in a 200‑person clinical trial. They also introduce Social Impact Partners, a nonprofit initiative to foster collaboration across the private, public, and government sectors in supporting Alzheimer's patients. The segment touches on promising new research around BioVie's investigational drug Bezisterim, which may reduce cellular 'rust buildup'-a key contributor to aging. Initial findings suggest it could play a role in slowing the aging process.
The Sustainable Green Team (OTC:SGTM)
CEO Tony Raynor outlines how SGTM transforms organic landfill waste into premium garden and soil products. What began as a mulch and tree removal business is now a regenerative brand with Amazon-ready offerings and national retail ambitions. SGTM is on a mission to restore soil health across America. Learn more at www.SGTMTech.com.
This episode is presented as sponsored programming on Bloomberg Television, reaching more than 124 million households nationwide. Further distribution includes:
New to The Street's YouTube channel with 3 million+ subscribers
Earned media coverage across major networks
Iconic outdoor billboards in Times Square and major U.S. metros
Sponsors for Episode #678 include MUSQ, IPOMarket.com, and Arrive AI TV Commercials.
'We're proud to deliver this high‑impact episode featuring leaders from five of the most innovative sectors,' said Vince Caruso, Co‑Founder and Executive Producer of New to The Street. 'This show exemplifies our mission to present breakthrough companies and ideas with credibility, scale, and reach.'
Media Contact:
Monica Brennan
New to The Street – Media Relations
Monica@NewToTheStreet.com
Watch & Learn More:
www.NewToTheStreet.com
www.IPOMarket.com
www.Arrive.ai
www.Hapbee.com
www.SGTMTech.com
www.BioVie.com
www.floki.com
SOURCE: New to The Street
View the original press release on ACCESS Newswire
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
What to know when using AI for your job search
Recruiters are seeing a rise in job candidates using artificial intelligence to prepare their resumes and even answer questions during live interviews. The trend is raising ethical concerns and prompting some employers to rethink their hiring practices. (July 13, 2025).
Miami Herald
a day ago
- Miami Herald
New to The Street Episode #678 to Air on Bloomberg TV Featuring Game-Changing Innovators in AI, Biotech, Blockchain, and Sustainability
Broadcast Premieres Saturday, July 12 at 6:30 PM EST on Bloomberg Television NEW YORK CITY, NY / ACCESS Newswire / July 12, 2025 / New to The Street, the leading multi-platform financial news series, announces its upcoming Bloomberg Television broadcast, airing Saturday, July 12 at 6:30 PM EST. Episode #678 showcases five transformative companies leading advancements across artificial intelligence, healthcare, sustainability, and blockchain. This dynamic lineup brings powerful insights from visionary leaders shaping the future of their respective industries. Featured Segments in Episode #678: Hapbee Technologies (OTCQB:HAPBF)NBA All-Star Jaylen Brown shares how Hapbee's groundbreaking wearable neurotech helps optimize sleep, recovery, and cognitive performance-without pharmaceuticals. The device uses proprietary low-frequency signals to emulate the effects of popular compounds, empowering users to choose how they feel, naturally and safely. Arrive AI (NASDAQ:ARAI)Live from Nasdaq MarketSite in Times Square, host Ana Berry interviews CEO Dan O'Toole and Chief Strategy Officer Neerav Shah as they unveil Arrive's secure smart mailbox technology. Phase 1 launches in healthcare and logistics; Phase 2 expands to every U.S. ZIP code. Arrive beat Amazon to the patent by four days, reinforcing its first-mover advantage in the $150B+ last-mile delivery sector. FLOKI (CRYPTO:FLOKI)Pedro Vidal, FLOKI's Community Relations Officer, discusses the explosive success of Valhalla, its play-to-earn metaverse game. As FLOKI expands across DeFi, NFTs, and blockchain gaming, its highly engaged global community cements it as one of crypto's most disruptive and culturally relevant brands. Learn more at BioVie Inc. (NASDAQ:BIVI)CEO Cuong Do and Chief Medical Officer Joseph Palumbo join Jane King to share meaningful updates on BioVie's advancement in clinical trials targeting Alzheimer's, Parkinson's, and Long COVID. BioVie is the only company to receive a federal grant to study Long COVID, and is currently enrolling patients in a 200‑person clinical trial. They also introduce Social Impact Partners, a nonprofit initiative to foster collaboration across the private, public, and government sectors in supporting Alzheimer's patients. The segment touches on promising new research around BioVie's investigational drug Bezisterim, which may reduce cellular "rust buildup"-a key contributor to aging. Initial findings suggest it could play a role in slowing the aging process. The Sustainable Green Team (OTC:SGTM)CEO Tony Raynor outlines how SGTM transforms organic landfill waste into premium garden and soil products. What began as a mulch and tree removal business is now a regenerative brand with Amazon-ready offerings and national retail ambitions. SGTM is on a mission to restore soil health across America. Learn more at This episode is presented as sponsored programming on Bloomberg Television, reaching more than 124 million households nationwide. Further distribution includes: New to The Street's YouTube channel with 3 million+ subscribersEarned media coverage across major networksIconic outdoor billboards in Times Square and major U.S. metros Sponsors for Episode #678 include MUSQ, and Arrive AI TV Commercials. Media Contact:Monica BrennanNew to The Street - Media RelationsMonica@ Watch & Learn More: SOURCE: New to The Street
Yahoo
a day ago
- Yahoo
Eli Lilly and Company (LLY): I Would 'Love' If Trump Praised The Company, Says Jim Cramer
We recently published . Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer recently discussed. Eli Lilly and Company (NYSE:LLY) is one of the most frequently discussed pharmaceutical stocks on Cramer's morning show. Over the course of this year, the CNBC TV host has maintained that the firm enjoys a lead in the weight loss drug market and aims to further expand its dominance by developing a robust manufacturing base. Cramer also believes that Eli Lilly and Company (NYSE:LLY) will benefit from introducing a weight loss pill along with a strong pipeline of drugs that targets diseases such as hypertension. His recent comments focused on an analyst note: '[On a Mizuho note saying POTUS would praise LLY and JNJ] I would love that, that won't happen. You know why it won't happen? See there's someone in the health and human services department that's not crazy about, about big pharma and the way we think about it. So there's not going to be a party thrown for you at Lilly. You know that GLP-1 is not a favorite of RFK Jr. Not a favorite. So no, no party for them.' Earlier, Cramer discussed Eli Lilly and Company (NYSE:LLY)'s CEO and investor expectations: 'David Ricks, if you spend time with him, has a view, of what should be done, that ends with the pill that you take every day, no shot . . but everyone's thinking that he doesn't have anything in the hopper. He's got heart coming up, he's going to have Alzheimer's coming up, oh buy. An array of pharmaceutical pills with the company's logo on the bottle. 'It's going be a trillion-dollar market cap, Ken Langone told me that. He's one of the largest investors in Lilly. He knows. While we acknowledge the potential of LLY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
